Bullseye Asset Management’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
KCM
RHJA
PHP
Bullseye Asset Management's OPRX Position: Q2 2026 in Review
Bullseye Asset Management increased its OptimizeRx (OPRX) stake by 14% in Q2 2026, buying an estimated $183K and bringing the position to 258,311 shares worth $1.48M. The position accounts for 0.75% of the portfolio, ranked #50.
Bullseye Asset Management first reported a position in OPRX in Q4 2019 and has held it in 27 quarters since. The position peaked at $16M in Q3 2021. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.
- Bullseye Asset Management held 258,311 shares of OptimizeRx worth $1.48M as of Q2 2026.
- Bullseye Asset Management bought 31,784 OptimizeRx shares in Q2 2026, an estimated $183K.
- OptimizeRx made up 0.75% of Bullseye Asset Management's portfolio in Q2 2026, its #50 holding.
- Bullseye Asset Management first reported a position in OptimizeRx in Q4 2019 and has held it in 27 quarters since.
- Bullseye Asset Management's OptimizeRx position peaked at $16M in Q3 2021.
- 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.
Based on Bullseye Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.